GeoVax opens third clinical trial site for testing HIV/AIDS vaccine

Links shared publicly online about this topic.

196
total visits

GeoVax opens third clinical trial site for testing HIV/AIDS vaccine

GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a third site for testing the therapeutic potential of its HIV/AIDS vaccine.

View full resource at news-medical.net

Tags: Vaccination, HIV, AIDS, STD, Clinical Trial, Biotech, Vaccine, News

Most Recently Shared on June 24, 2011 at 5:51 am By:

News-Medical.Net

HIV/AIDS News: GeoVax opens third clinical trial site for testing HIV/AIDS vaccine: GeoVax Labs, Inc., a biotech... http://bit.ly/k0lu6U

11 months ago...

Retweet

Favorite

Also Shared By:

News-Medical.Net

GeoVax Initiates Third Site For Therapeutic Testing Of Its HIV Vaccine - QualityPoint Technologies

qualitypointtech.net — “GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced the opening of a third site for testing the therapeutic potential of its HIV/AIDS vaccine. The Los Angeles-based AIDS Research Alliance (ARA) will join with two existing members of GeoVax's clinical trial site team: the AIDS Research Consortium of Atlanta and the Alabama Vaccine Research Clinic at the University of Alabama at Birmingham. The ARA is the nation's ” View full resource at qualitypointtech.net